Pulmonary Vascular Disease Related to Hemodynamic Stress in the Pulmonary Circulation

Overview

Journal Compr Physiol

Specialty Physiology

Date 2013 Jun 6

PMID 23737167

Citations 2

Authors

Stephen Y Chan

Joseph Loscalzo

Affiliations

Soon will be listed here.

Abstract

Hemodynamic stress in the pulmonary vessel is directly linked to the development of vascular remodeling and dysfunction, ultimately leading to pulmonary hypertension. Recently, some advances have been made in our molecular understanding of the exogenous upstream stimuli that initiate hemodynamic pertubations as well as the downstream vasoactive effectors that control these responses. However, much still remains unknown regarding how these complex signaling pathways connect in order to result in these characteristic pathophysiological changes. This chapter will describe our current understanding of and needed areas of research into the clinical, physiological, and molecular changes associated with pressure/volume overload in the pulmonary circulation.

Citing Articles

Reversal of Pulmonary Hypertension in a Human-Like Model: Therapeutic Targeting of Endothelial DHFR.

Murugesan P, Zhang Y, Huang Y, Zong N, Youn J, Chen W Circ Res. 2024; 134(4):351-370.

PMID: 38299369 PMC: 10880947. DOI: 10.1161/CIRCRESAHA.123.323090.

Quantitative Xe MRI detects early impairment of gas-exchange in a rat model of pulmonary hypertension.

Virgincar R, Nouls J, Wang Z, Degan S, Qi Y, Xiong X Sci Rep. 2020; 10(1):7385.

PMID: 32355256 PMC: 7193602. DOI: 10.1038/s41598-020-64361-1.

References

Christman B, McPherson C, Newman J, King G, Bernard G, GROVES B . An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med. 1992; 327(2):70-5. DOI: 10.1056/NEJM199207093270202. View

Cox C, Linden J, Said S . VIP elevates platelet cyclic AMP (cAMP) levels and inhibits in vitro platelet activation induced by platelet-activating factor (PAF). Peptides. 1984; 5(2):325-8. DOI: 10.1016/0196-9781(84)90228-6. View

Ali M, Ping C, Mok Y, Ling L, Whiteman M, Bhatia M . Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide?. Br J Pharmacol. 2006; 149(6):625-34. PMC: 2014646. DOI: 10.1038/sj.bjp.0706906. View

Lee S, Shroyer K, Markham N, Cool C, Voelkel N, Tuder R . Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest. 1998; 101(5):927-34. PMC: 508641. DOI: 10.1172/JCI1910. View

Nagaoka T, Morio Y, Casanova N, Bauer N, Gebb S, McMurtry I . Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats. Am J Physiol Lung Cell Mol Physiol. 2003; 287(4):L665-72. DOI: 10.1152/ajplung.00050.2003. View

Dorfmuller P, Zarka V, Durand-Gasselin I, Monti G, Balabanian K, Garcia G . Chemokine RANTES in severe pulmonary arterial hypertension. Am J Respir Crit Care Med. 2002; 165(4):534-9. DOI: 10.1164/ajrccm.165.4.2012112. View

Li F, Xia W, Li A, Zhao C, Sun R . Inhibition of rho kinase attenuates high flow induced pulmonary hypertension in rats. Chin Med J (Engl). 2007; 120(1):22-9. View

Reddy V, Meyrick B, Wong J, Khoor A, Liddicoat J, Hanley F . In utero placement of aortopulmonary shunts. A model of postnatal pulmonary hypertension with increased pulmonary blood flow in lambs. Circulation. 1995; 92(3):606-13. DOI: 10.1161/01.cir.92.3.606. View

Chaouat A, Coulet F, Favre C, Simonneau G, Weitzenblum E, Soubrier F . Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension. Thorax. 2004; 59(5):446-8. PMC: 1746994. DOI: 10.1136/thx.2003.11890. View

10.

Hassoun P, Thappa V, Landman M, Fanburg B . Endothelin 1: mitogenic activity on pulmonary artery smooth muscle cells and release from hypoxic endothelial cells. Proc Soc Exp Biol Med. 1992; 199(2):165-70. DOI: 10.3181/00379727-199-43342. View

11.

Farber H, Loscalzo J . Pulmonary arterial hypertension. N Engl J Med. 2004; 351(16):1655-65. DOI: 10.1056/NEJMra035488. View

12.

Ishikura K, Yamada N, Ito M, Ota S, Nakamura M, Isaka N . Beneficial acute effects of rho-kinase inhibitor in patients with pulmonary arterial hypertension. Circ J. 2006; 70(2):174-8. DOI: 10.1253/circj.70.174. View

13.

Black S, Sanchez L, Mata-Greenwood E, BEKKER J, Steinhorn R, Fineman J . sGC and PDE5 are elevated in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2001; 281(5):L1051-7. DOI: 10.1152/ajplung.2001.281.5.L1051. View

14.

Teichert-Kuliszewska K, Kutryk M, Kuliszewski M, Karoubi G, Courtman D, Zucco L . Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension. Circ Res. 2005; 98(2):209-17. DOI: 10.1161/01.RES.0000200180.01710.e6. View

15.

Mata-Greenwood E, Meyrick B, Soifer S, Fineman J, Black S . Expression of VEGF and its receptors Flt-1 and Flk-1/KDR is altered in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2003; 285(1):L222-31. DOI: 10.1152/ajplung.00388.2002. View

16.

Shimokubo T, Sakata J, Kitamura K, Kangawa K, Matsuo H, Eto T . Augmented adrenomedullin concentrations in right ventricle and plasma of experimental pulmonary hypertension. Life Sci. 1995; 57(19):1771-9. DOI: 10.1016/0024-3205(95)02155-c. View

17.

Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B . Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science. 2001; 293(5539):2449-52. DOI: 10.1126/science.1062688. View

18.

Mitani Y, Zaidi S, Dufourcq P, Thompson K, Rabinovitch M . Nitric oxide reduces vascular smooth muscle cell elastase activity through cGMP-mediated suppression of ERK phosphorylation and AML1B nuclear partitioning. FASEB J. 2000; 14(5):805-14. DOI: 10.1096/fasebj.14.5.805. View

19.

Aldred M, Vijayakrishnan J, James V, Soubrier F, Gomez-Sanchez M, Martensson G . BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension. Hum Mutat. 2006; 27(2):212-3. DOI: 10.1002/humu.9398. View

20.

Soderman C, Eriksson L, Juhlin-Dannfelt A, Lundberg J, BROMAN L, Holmgren A . Effect of vasoactive intestinal polypeptide (VIP) on pulmonary ventilation-perfusion relationships and central haemodynamics in healthy subjects. Clin Physiol. 1993; 13(6):677-85. DOI: 10.1111/j.1475-097x.1993.tb00482.x. View